亚太宫内避孕装置市场 - 行业趋势及 2029 年预测

请求目录 请求目录 与分析师交谈 与分析师交谈 立即购买 立即购买 购买前请咨询 提前咨询 免费样本报告 免费样本报告

亚太宫内避孕装置市场 - 行业趋势及 2029 年预测

  • Healthcare
  • Upcoming Report
  • Dec 2021
  • Asia-Pacific
  • 150 页面
  • 桌子數: 30
  • 图号: 50

Asia Pacific Intrauterine Contraceptive Devices Market

市场规模(十亿美元)

CAGR :  % Diagram

Diagram Forecast Period
2023 –2029
Diagram Market Size (Base Year)
USD MILLION
Diagram Market Size (Forecast Year)
USD 2,555.73 Million
Diagram CAGR
%
Diagram Major Markets Players
  • Melbea AG
  • Pregna International Limited
  • Meril Life Sciences Pvt.
  • Medu Scientific Ltd
  • SBM Corporation

>亚太宫内避孕装置市场,按产品类型(激素、IUCD 和铜 IUCD)、最终用途(医院、妇科诊所、社区医疗保健和其他)、国家(日本、中国、印度、韩国、澳大利亚、新加坡、马来西亚、泰国、印度尼西亚、菲律宾、亚太其他地区)划分的行业趋势和预测到 2029 年。

亚太宫内节育器市场

宫内节育器市场分析及见解

全球范围内意外怀孕的发生率不断上升,制造商越来越注重采用先进技术,研发能力也不断提高,这些因素都导致宫内节育器市场价值上升。Data Bridge Market Research 分析称,预测期内(2022 年至 2029 年),宫内节育器市场将呈现约 10.55% 的复合年增长率。

宫内节育器 (IUD) 是一种 T 形、小型的避孕装置,可插入子宫以防止受孕或怀孕。宫内节育器 (IUD) 可防止卵子和精子相遇。这通过两种方式实现:要么在精子进入输卵管的途中将其固定住,要么改变子宫内膜,使卵子无法受精。

医疗技术的不断进步、意外和未满足的避孕需求的不断增加以及印度、韩国、马来西亚、越南、非洲和中东国家等新兴经济体提供的丰厚机会将推动市场增长率。发展医疗基础设施的公共支出不断增加,加上政府和非政府组织为传播人口控制意识而采取的举措不断增多,将进一步推动市场价值的增长。个人可支配收入的增长也将成为其他重要的市场增长决定因素。

然而,缺乏专业人员和技术专家、不利的报销情况以及发展中和欠发达经济体的预算限制将在上述预测期内对市场的增长构成挑战。此外,宗教团体的限制、异位妊娠的威胁和盆腔炎的发生也将阻碍市场增长率。

本宫内节育器市场报告详细介绍了最新发展、贸易法规、进出口分析、生产分析、价值链优化、市场份额、国内和本地市场参与者的影响,分析了新兴收入领域的机会、市场法规的变化、战略市场增长分析、市场规模、类别市场增长、应用领域和主导地位、产品批准、产品发布、地域扩展、市场技术创新。如需了解有关宫内节育器市场的更多信息,请联系 Data Bridge Market Research 获取分析师简报,我们的团队将帮助您做出明智的市场决策,实现市场增长。

亚太宫内避孕器市场范围和市场规模

宫内节育器市场根据产品类型和最终用途进行细分。这些细分市场之间的增长情况将帮助您分析行业中增长缓慢的细分市场,并为用户提供有价值的市场概览和市场洞察,帮助他们做出战略决策,确定核心市场应用。

  • 根据产品类型,亚太宫内节育器市场分为激素型宫内节育器和铜型宫内节育器。
  • 亚太宫内避孕装置市场也根据最终用途细分为医院、妇科诊所、社区医疗保健等。

宫内节育器市场国家层面分析

宫内节育器市场根据产品类型和最终用途进行细分。

宫内节育器市场报告涵盖的国家包括亚太地区的中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾和亚太地区 (APAC) 的其他地区。

由于医疗保健行业的快速发展以及政府对宫内避孕器的大力推广,中国在亚太宫内避孕器市场占据主导地位。

宫内节育器市场报告的国家部分还提供了影响单个市场因素和国内市场监管变化,这些因素和变化会影响市场的当前和未来趋势。消费量、生产地点和产量、进出口分析、价格趋势分析、原材料成本、下游和上游价值链分析等数据点是用于预测单个国家市场情景的一些主要指标。此外,在提供国家数据的预测分析时,还考虑了全球品牌的存在和可用性以及由于来自本地和国内品牌的激烈或稀少的竞争而面临的挑战、国内关税和贸易路线的影响。

医疗保健基础设施增长安装基础和新技术渗透

宫内节育器市场还为您提供每个国家/地区资本设备医疗支出增长、数字医疗技术市场不同类型产品的安装基数、使用生命线曲线的技术影响以及医疗监管情景的变化及其对宫内节育器市场的影响的详细市场分析。数据涵盖 2010 年至 2020 年的历史时期。

竞争格局和宫内避孕器市场份额分析

宫内节育器市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对宫内节育器市场的关注有关。

宫内节育器市场报告中的主要参与者包括 Melbea AG、Pregna International Limited、Meril Life Sciences Pvt. Ltd.、Medu Scientific Ltd、SBM Corporation、ZheijangDaji Medical Instruments, Ltd、Teva Pharmaceuticals Industries Ltd.、DKT INTERNATIONAL、Bernstein Liebhard LLP.、SMB Corporation of India 等。


SKU-

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

研究方法

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

可定制

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Frequently Asked Questions

China is the dominating region of the Asia-Pacific Intrauterine Contraceptive Devices Market.
The Asia-Pacific Intrauterine Contraceptive Devices Market growth rate will be 10.55% by 2029.
The Growing technological advancement in medical technology, rising rate of unintended and unmet contraceptive needs and lucrative opportunities offered by emerging economies such as India, South Korea, Malaysia, Vietnam, Africa, and Middle Eastern countries are the growth drivers of the Asia-Pacific Intrauterine Contraceptive Devices Market.
The type of product and end-use are the factors on which the Asia-Pacific Intrauterine Contraceptive Devices Market research is based.
The major companies in the Asia-Pacific Intrauterine Contraceptive Devices Market are Melbea AG, Pregna International Limited, Meril Life Sciences Pvt. Ltd., Medu Scientific Ltd, SBM Corporation, ZheijangDaji Medical Instruments, Ltd, Teva Pharmaceuticals Industries Ltd., DKT INTERNATIONAL, Bernstein Liebhard LLP.